Acasti Pharma Inc.
ACST
Rang in aandelen
#29738
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Aandeelprijs
$0.41258382
Laatst gesynchroniseerd: 2023-03-27
Marktkapitalisatie
$18.41M
Verandering (1 dag)
-0.09%
Verandering (1 jaar)
-87.42%
Land
CA
Handel Acasti Pharma Inc. (ACST)
Categorie
Healthcare
Koersgeschiedenis voor Acasti Pharma Inc. (ACST)
Hoogste slotkoers: $3.14 op 2024-11-01
Laagste slotkoers: $726.00 op 2012-02-01
Laagste slotkoers: $726.00 op 2012-02-01
Koersgeschiedenis van Acasti Pharma Inc. van 2012 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2024 | 34.72% |
| 2023 | -9.30% |
| 2022 | -64.98% |
| 2021 | -48.82% |
| 2020 | -86.25% |
| 2019 | 209.96% |
| 2018 | -47.13% |
| 2017 | 2.86% |
| 2016 | -43.73% |
| 2015 | -54.07% |
| 2014 | -59.53% |
| 2013 | -48.78% |
| 2012 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $760.15 | 8.04% |
CH
|
